Prevalence and determinants of non-adherence to Imatinib in the first 3-months treatment among newly diagnosed Ethiopian's with chronic myeloid leukemia.

by Atalay Mulu Fentie, Fishatsion Tadesse, Ephrem Engidawork, Am Gebremedhin
Published 2019-01-01